Pegintron/Rebetol Combo Pack (peginterferon alfa-2b + ribavirin) / Merck (MSD)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pegintron/Rebetol Combo Pack (peginterferon alfa-2b + ribavirin) / Merck (MSD)
NCT00728494: Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

Completed
N/A
99
Europe
PegIntron (peginterferon alfa-2b; SCH 54031), PegIntron, Rebetol (ribavirin; SCH 18908), Rebetol, Patient Assistance Program, Support program
Merck Sharp & Dohme LLC
Hepatitis C, Chronic, Hepatitis C
12/07
12/07
NCT00724295: Safety and Efficacy of PegIntron and Rebetol Combination Therapy in Patients With Chronic Hepatitis C in Japan (Study P04505)

Completed
N/A
1077
Japan
peginterferon alfa-2b, PegIntron, SCH 54031, ribavirin, Rebetol, SCH 18908
Merck Sharp & Dohme LLC
Hepatitis C, Chronic, Hepatitis C
12/08
12/08
NCT00724230: Safety and Efficacy of PegIntron Plus Rebetol in Patients With Chronic Hepatitis C in Japan, Excluding (1) Subjects With HCV Genotype 1 and High Viral Load, and (2) Interferon-naïve Subjects With Low Viral Load (Study P04841)(COMPLETED)

Completed
N/A
505
Japan
PegIntron (peginterferon alfa-2b; SCH 54031), SCH 54031, Rebetol (ribavirin; SCH 18908), SCH 18908
Merck Sharp & Dohme LLC
Hepatitis C, Chronic, Hepatitis C
12/08
12/08
MK-4031-245, NCT00723892: Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)

Completed
N/A
614
Europe
Peginterferon alfa-2b (PegIntron), PegIntron pen, SCH 54031, ViraferonPeg, Rebetol (Ribavirin), Ribavirin, SCH 18908, Psychotherapy support program
Merck Sharp & Dohme LLC
Hepatitis C, Chronic, Hepacivirus
05/09
05/09

Download Options